MINI LONG - REVVITY Share Price

Certificat

MINI L PERKINEL

GB00BQRMMW62

Market Closed - Nasdaq Stockholm 20:22:13 14/02/2024 GMT
49.08 ^SEK	+3.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart REVVITY, INC.

Latest news about REVVITY, INC.

GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments	06-18	CI
Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM	06-10
Revvity to Present at Goldman Sachs Global Healthcare Conference	05-28	BU
Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	05-14

More news

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	REVVITY, INC.
Issuer	Morgan Stanley
	MINI L PERKINEL
ISIN	GB00BQRMMW62
Date issued	02/11/2023
Strike	58.12 $
Maturity	Unlimited
Parity	10 : 1
Emission price	- kr
Emission volume	N/A
Settlement	cash
Currency	SEK

Technical Indicators

Highest since issue	49.08 kr
Lowest since issue	47.42 kr
Spread	1.36 kr
Spread %	2.62%

Company Profile

Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).

Sector

More about the company